Tag: Targeted Drug EGFR RTK Inhibitors for NSCLC Market

  • Japan Targeted Drug EGFR RTK Inhibitors for NSCLC Market By Application

    by

    in

    The Japan Targeted Drug EGFR RTK Inhibitors for NSCLC Market size is reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a compound annual growth rate (CAGR) of xx.x% from 2024 to 2031. Japan Targeted Drug EGFR RTK Inhibitors for NSCLC Market By Application First-Line Treatment…